Back to Results
First PageMeta Content
Blood / Coagulation system / Biology / Recombinant proteins / Baxalta / Von Willebrand disease / Haemophilia / Factor VIII / PEGylation / Baxter International / Factor VII / Recombinant factor VIIa


UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •
Add to Reading List

Document Date: 2015-07-30 13:12:07

Open Document

File Size: 195,30 KB

Share Result on Facebook
UPDATE